World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
22823
World Ranking
2476
National Ranking
1184

Research.com Recognitions

  • 2016 - Albert B. Sabin Gold Medal, Sabin Vaccine Institute

Overview

George R. Siber is affiliated with Johns Hopkins University in the United States. Their research primarily focuses on the field of Medicine, with a particular emphasis on Infectious Diseases. Their work also covers Epidemiology, Health, Animal Science and Zoology, and Molecular Biology.

The scientist's scholarly output extensively covers topics related to SARS-CoV-2 and COVID-19 Research, including COVID-19 Clinical Research Studies and Vaccine Coverage and Hesitancy. Additional topics addressed include Pneumonia and Respiratory Infections, Animal Virus Infections Studies, Pneumocystis jirovecii pneumonia detection and treatment, and Respiratory viral infections research.

Frequent publication venues for their work include:

  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Research Square (Research Square)
  • The Journal of Infectious Diseases
  • The Lancet

Among recent papers authored or co-authored by George R. Siber are:

  • Evidence for antibody as a protective correlate for COVID-19 vaccines, 2021, Vaccine
  • Towards a population-based threshold of protection for COVID-19 vaccines, 2021, Vaccine
  • Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial, 2022, The Lancet
  • Evidence for antibody as a protective correlate for COVID-19 vaccines, 2021, bioRxiv (Cold Spring Harbor Laboratory)
  • Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years, 2022, Vaccine

Frequent collaborators include:

  • Donna M. Ambrosino
  • Ralf Clemens
  • David Goldblatt
  • Branda Hu
  • Igor Smolenov

Best Publications

  • Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

    Steven Black;Henry Shinefield;Bruce Fireman;Edwin Lewis

  • Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

    Eskola J;Kilpi T;Palmu A;Jokinen J

  • Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

    William P. Hausdorff;John Bryant;Peter R. Paradiso;George R. Siber

  • Evidence for antibody as a protective correlate for COVID-19 vaccines

    Kristen A. Earle;Donna M. Ambrosino;Andrew Fiore-Gartland;David Goldblatt

  • Adjuvants for human vaccines—current status, problems and future prospects☆

    Rajesh K. Gupta;George R. Siber

  • Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.

    Simin Nikbin Meydani;M. Meydani;J. B. Blumberg;L. S. Leka

  • Recurrent Sinopulmonary Infection and Impaired Antibody Response to Bacterial Capsular Polysaccharide Antigen in Children with Selective IgG-Subclass Deficiency

    Dale T. Umetsu;Donna M. Ambrosino;Isabella Quinti;George R. Siber

  • Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

    Katherine L O'Brien;Lawrence H Moulton;Raymond Reid;Robert Weatherholtz

  • Biodegradable microspheres as controlled-release tetanus toxoid delivery systems

    María J. Alonso;Rajesh K. Gupta;Caroline Min;George R. Siber

  • Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

    Luis Jódar;Jay Butler;George Carlone;Ron Dagan

  • The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II

    William P. Hausdorff;John Bryant;Carolyn Kloek;Peter R. Paradiso

  • Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

    George R. Siber;Ih Chang;Sherryl Baker;Philip Fernsten

  • Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

    Andrés de Roux;B. Schmöele-Thoma;G. R. Siber;J. G. Hackell

  • Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

    Henry R. Shinefield;Steven Black;Paula Ray;Ih Chang

  • Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children.

    William P Hausdorff;George Siber;Peter R Paradiso

  • Determinants of Release Rate of Tetanus Vaccine from Polyester Microspheres

    Maria J. Alonso;Smadar Cohen;Tae G. Park;Rajesh K. Gupta

  • Towards a population-based threshold of protection for COVID-19 vaccines

    Unknown

  • How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem

    Marc Lipsitch;George R. Siber

  • An immunodeficiency characterized by impaired antibody responses to polysaccharides.

    Donna M. Ambrosino;George R. Siber;Barbara A. Chilmonczyk;Julia B. Jernberg

  • Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.

    D M Ambrosino;G Schiffman;E C Gotschlich;P H Schur

  • Serum Serotype-Specific Pneumococcal Anticapsular Immunoglobulin G Concentrations after Immunization with a 9-Valent Conjugate Pneumococcal Vaccine Correlate with Nasopharyngeal Acquisition of Pneumococcus

    Ron Dagan;Noga Givon-Lavi;Drora Fraser;Marc Lipsitch

  • Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine

    Stephen K Obaro;M. C. Steinhoff;N. Shahid;G. Siber

Frequent Co-Authors

Katherine L. O’Brien
Katherine L. O’Brien Johns Hopkins University
Mathuram Santosham
Mathuram Santosham Johns Hopkins University
Lawrence H. Moulton
Lawrence H. Moulton Johns Hopkins University
Keith P. Klugman
Keith P. Klugman Bill & Melinda Gates Foundation
Mark C. Steinhoff
Mark C. Steinhoff Cincinnati Children's Hospital Medical Center
Steven Black
Steven Black Cincinnati Children's Hospital Medical Center
William C. Gruber
William C. Gruber Pfizer (United States)
Robert W. Finberg
Robert W. Finberg University of Massachusetts Chan Medical School
Marc Lipsitch
Marc Lipsitch Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens the door to various career opportunities, many of which can be enhanced through specialized nursing programs. For professionals aiming to advance their clinical skills, exploring acute care nurse practitioner programs is a valuable step. These programs prepare nurses for high-acuity settings, complementing knowledge gained from immunology studies.

For those looking to accelerate their nursing education, an accelerated nurse practitioner program can provide a faster pathway to advanced practice roles. These online options allow students to balance studies with other commitments while gaining expertise in immunology-related healthcare fields.

Beginning a nursing career without prior experience? Many universities offer online ABSN programs for non nurses, designed to transition individuals into nursing roles efficiently. These programs often integrate foundational science knowledge alongside clinical training, essential for immunology-focused careers.

When considering entry points, some students prefer the easiest ABSN programs to get into, which may offer more accessible admissions criteria. Selecting the right program can pave the way to rewarding positions in immunology research or clinical practice, enhancing career growth in the healthcare sector.

Best Scientists Citing George R. Siber

Trending Scientists